Uncovering Bupi Yishen Formula Pharmacological Mechanisms Against Chronic Kidney Disease by Network Pharmacology and Experimental Validation

Chronic kidney disease (CKD) is a leading public health problem with high morbidity and mortality, but the therapies remain limited. Bupi Yishen Formula (BYF) - a patent traditional Chinese medicine (TCM) formula - has been proved to be effective for CKD treatment in a high-quality clinical trial. H...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Difei Zhang, Bingran Liu, Xina Jie, Jiankun Deng, Zhaoyu Lu, Fuhua Lu, Xusheng Liu
Format: article
Langue:EN
Publié: Frontiers Media S.A. 2021
Sujets:
Accès en ligne:https://doaj.org/article/7799d63a89b34a9a8583509f6147c911
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!